Authors
Latest:
Devices, Not Just Doctors, Should Engage PatientsBut many products are designed for medical professionals, not consumers, and that needs to change.
Latest:
Year-Round Solutions Beyond the Influenza SeasonAs the margin between acquisition cost and sales price continues to narrow for traditional community pharmacy medication dispensing, many pharmacies are increasingly turning to service-based opportunities to improve their profitability.
Latest:
Legal Issues With Naloxone Availability Conferring Authority and Insulating From LiabilityThe rise of opioid overdoses nationally has expanded the role of pharmacists and advocacy for pharmacists to apply their knowledge and talents to emergency situations.
Latest:
Factors Associated With Employee Participation in a Value-Based Insurance Design InitiativeWe describe enrollment in a voluntary VBID initiative. Uptake was suboptimal, suggesting that barriers to enrollment may have significant implications for the overall effectiveness of VBID.
Latest:
Real-World Immunoglobulin Dose Adjustments and Impact on Utilization and CostsReal-world dose adjustments occurred in patients with primary immunodeficiency who switched from intravenous immunoglobulin to subcutaneous immunoglobulin 20%, with resulting implications for payers, patients, and plasma collection and supply.
Latest:
New Oral Anticoagulants for Stroke Prevention in Atrial FibrillationThis review summarizes the safety and efficacy of 3 new orally active anticoagulant drugs (dabigatran, rivaroxaban, apixaban) that can be used as alternatives to warfarin.
Latest:
Sunovion Pharmaceuticals' LatudaThe FDA approved Sunovion Pharmaceuticals' Latuda (lurasidone HCL), an atypical antipsychotic used to treat schizophrenia in adults 18 years and older.
Latest:
Economic Outcomes of Warfarin Discontinuation Among Patients with Atrial FibrillationThis study seeks to determine the economic effects of warfarin discontinuation in patients with nonvalvular atrial fibrillation.
Latest:
Evaluation of Therapeutic Interchange From Donepezil to Galantamine Extended-ReleaseTherapeutic interchange from donepezil to galantamine extended-release: a 3-month analysis.
Latest:
The Journey of Commitment to Ultra-Rare Disease Patients: A Supportive Business ModelOver the last 5 years, more than 4000 FDA-regulated clinical trials were initiated worldwide for rare disease treatments.
Latest:
Asembia 2017: A Look Back and a Peek AheadValue-based care and direct and indirect remuneration fees among the hottest topics at annual summit.
Latest:
CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma and Acute Lymphoblastic LeukemiaCAR T-cell therapy involves collecting a patient’s blood, extracting the T cells within the blood, and returning the remaining blood back into the body, a process called leukapheresis.
Latest:
The 3 Drug Classes for Experimental Ebola TreatmentTreatment success often depends on the stage of the infection in which they are administered.
Latest:
Student Advocacy at NACDS RxIMPACT DayStudents share personal stories of their experiences serving as advocates at the National Association of Chain Drug Stores' RxIMPACT day in Washington, DC.
Latest:
New Oral Anticoagulants: Implications for Health SystemsThe new oral anticoagulants that have become available in recent years have added significant complexity to the prevention of stroke in patients with atrial fibrillation.
Latest:
Walgreens Split-Fill Case Study: Preventing Waste Through Extension of a Cost-Saving ProgramAs part of its pharmacist-driven ConnectedCare Oral Oncology Program, Walgreens Specialty Pharmacy recently conducted a unique 3-month monitored-dispense pilot program, which reflects continued innovation, additional cost savings, and improved health care system communication.
Latest:
What Are the Drug Supply Chain Security Act's Key Provisions?The purpose of the drug supply chain security act (DSCSA) was to create an electronic system to track and trace certain prescription drugs in the United States.
Latest:
Persistence With Antiarrhythmics and the Impact on Atrial Fibrillation–Related OutcomesRetrospective analysis of claims data showed that persistence with amiodarone and sotalol was generally poor.
Latest:
Burden of Autosomal Dominant Polycystic Kidney Disease: Systematic Literature ReviewThe authors present a review of the literature for autosomal dominant polycystic kidney disease to characterize its impact on patients and healthcare systems.
Latest:
Vitamin E Research: Current Science and Future DirectionsFree Radical Biology and Medicine has published a review of emerging aspects and future directions of vitamin E research in its November 2016 issue.
Latest:
Virtual Verification Elevates TechniciansStaying on track with immunizations means modifying workflows and reallocating pharmacy staff time.
Latest:
Breast Cancer Armamentarium Offers New Options for PatientsMost women with breast cancer receive treatment post surgery, such as chemotherapy, hormone therapy, and radiation. Targeted therapy is useful against cancers that have spread to distant parts of the body.
